Jellyfish medical findings

How the jellyfish surprised science and what the medical implications Results are encouraging Aenean vitae neque est. Proin aliquam, lacus non ullamcorper elementum, diam eros faucibus orci, sed lobortis lectus urna egestas ligula. Morbi viverra, orci ac sodales consectetur, erat justo dictum urna, sodales ultrices [...]

By |2017-06-30T03:03:18-04:00June 30th, 2017|In the press|0 Comments

Reduced medicine side effects

Reduced side effects of medicine Results are encouraging Aenean vitae neque est. Proin aliquam, lacus non ullamcorper elementum, diam eros faucibus orci, sed lobortis lectus urna egestas ligula. Morbi viverra, orci ac sodales consectetur, erat justo dictum urna, sodales ultrices nulla diam placerat ipsum. Donec [...]

By |2017-06-30T02:09:05-04:00June 30th, 2017|In the press|0 Comments

Consistent testing cannot fail

Consistent testing cannot fail Results are encouraging Aenean vitae neque est. Proin aliquam, lacus non ullamcorper elementum, diam eros faucibus orci, sed lobortis lectus urna egestas ligula. Morbi viverra, orci ac sodales consectetur, erat justo dictum urna, sodales ultrices nulla diam placerat ipsum. Donec [...]

By |2017-06-29T19:09:47-04:00June 29th, 2017|In the press|0 Comments

Alternative science benefits

Alternative science and the benefits Results are encouraging Aenean vitae neque est. Proin aliquam, lacus non ullamcorper elementum, diam eros faucibus orci, sed lobortis lectus urna egestas ligula. Morbi viverra, orci ac sodales consectetur, erat justo dictum urna, sodales ultrices nulla diam placerat ipsum. Donec [...]

By |2017-06-29T19:08:39-04:00June 29th, 2017|In the press|0 Comments

New Investments and Approvals Spur the Development of Biologics

Although still expensive to develop and produce, large molecules are rapidly taking over. by Susan Thompson, Technical Director at VxP Biologics For most of the previous century, much of pharmaceutical research focused on the development of small-molecule “blockbuster” drugs, which treated a wide variety of diseases for a great number of patients, and could thus [...]

By |2018-02-07T09:33:52-05:00June 18th, 2017|Manufacturing, Research & Development|0 Comments

Development of Biologics – Monoclonal Antibodies

Monoclonal antibody approval success rates vary widely, but are on the increase overall. by Raymond E Peck, CEO of VxP Biologics The human monoclonal antibody (mAb) sector has witnessed tremendous growth since its inception in the early 1980s. Despite a rocky start, new technologies in molecule generation spurred rapid development throughout the 1990s; and in [...]

By |2018-02-07T09:36:56-05:00June 16th, 2017|Research & Development|0 Comments

Sterile Injectables for Clinical Trials

Growth continues, but logistical and regulatory hurdles limit worldwide supplies. by Susan Thompson, Technical Director at VxP Biologics The global market for sterile injectables continues to expand at an impressive rate. In 2015, this market was valued at $299.7 billion; and its compound annual growth rate (CAGR) is projected at 6.9 percent, at least through [...]

By |2018-02-07T09:33:35-05:00June 6th, 2017|Manufacturing, Research & Development|0 Comments
Go to Top